Foamix stock bub­bles high­er on lat­est ac­ne PhI­II; Con­cen­tric Anal­gesic gets an FDA 'break­through'

→ Shares of Foamix Ther­a­peu­tics $FOMX soared Tues­day night on news that their third Phase III study of a new ac­ne med suc­ceed­ed in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.